This year has been one of the most formative for women in medtech leadership roles as representation in the C-suite has reached a new high.
Just 23% of the top executives at the world’s 100 largest medical device companies are women, according to an analysis of Medical Design & Outsourcing‘s annual Big 100 ranking of the top revenue-generating medtech companies.
While that number is up 2 percentage points from 2021, the average composition within the top 100 companies is also up slightly to 22%.
This year has been one of the most formative for women in leadership roles. There were 50 new C-suite appointments. However, 2020 seemingly started the shift in leadership diversity. That year, 37 women moved into C-suite roles in the top 100 companies, followed by 34 new appointments in 2021. Overall, women have moved into 121 new roles in the last three years.
“The fact that the management teams are now tapping into this in 2020 and…